Terumo Acquires OrganOx for $1.5B, Expanding into Organ Transplantation with Advanced Preservation Technology

Oxford, UK and Madison, NJ, August 24, 2025 (Globe Newswire) -- Terumo Corporation will acquire OrganOx Limited for approximately $1.5 billion, entering the organ transplantation sector with a portfolio of advanced organ preservation devices. OrganOx’s normothermic machine perfusion technology extends organ viability, improves utilization of marginal donor organs, and enhances transplant outcomes. The deal leverages Terumo’s global scale to expand access to OrganOx’s FDA-approved devices, which have already supported more than 6,000 transplant procedures worldwide.

Read full article here.